Our vision is that our device would become the leading technology in EVs isolation, facilitating the development of new EVs-based therapeutics and diagnostics.

The Problem

The separation of EVs from raw physiological fluids is a challenging task that often requires sample pretreatment and multiple steps, specialized laboratory equipment, and skilled operators. It may result in insufficient yield, low purity, and compromised integrity.

The Solution

At the soon-to-be-incorporated ETH spinoff start-up Acytronix, we have developed a portable device for the separation of EVs directly from physiological fluids.